Found: 9
Select item for more details and to access through your institution.
Nanoskalige, biologisch abbaubare organisch-anorganische Hybride für effiziente Zellaufnahme und Wirkstofftransport.
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 47, p. 15063, doi. 10.1002/ange.201606065
- By:
- Publication type:
- Article
Eine chemoenzymatische Kupplungsstrategie zur Immobilisierung von Proteinen auf kristalliner Nanocellulose.
- Published in:
- Angewandte Chemie, 2014, v. 126, n. 46, p. 12826, doi. 10.1002/ange.201404616
- By:
- Publication type:
- Article
Mass spectrometry for quality control of bispecific antibodies after SDS‐PAGE in‐gel digestion.
- Published in:
- Biotechnology & Bioengineering, 2021, v. 118, n. 8, p. 3069, doi. 10.1002/bit.27817
- By:
- Publication type:
- Article
An IgG‐based bispecific antibody for improved dual targeting in PSMA‐positive cancer.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 2, p. 1, doi. 10.15252/emmm.201911902
- By:
- Publication type:
- Article
Nanoscale Biodegradable Organic-Inorganic Hybrids for Efficient Cell Penetration and Drug Delivery.
- Published in:
- Angewandte Chemie International Edition, 2016, v. 55, n. 47, p. 14842, doi. 10.1002/anie.201606065
- By:
- Publication type:
- Article
A Chemoenzymatic Approach to Protein Immobilization onto Crystalline Cellulose Nanoscaffolds.
- Published in:
- Angewandte Chemie International Edition, 2014, v. 53, n. 46, p. 12618, doi. 10.1002/anie.201404616
- By:
- Publication type:
- Article
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2759, doi. 10.1007/s00432-022-04039-5
- By:
- Publication type:
- Article
IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3941, doi. 10.3390/cancers14163941
- By:
- Publication type:
- Article
CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4596, doi. 10.3390/cancers13184596
- By:
- Publication type:
- Article